Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration

IntroductionCirculating very-long-chain saturated fatty acids (VLSFAs) may attenuate age-related cognitive decline, but their direct association with neurodegeneration biomarkers and the underlying mechanisms remain unclear.MethodsThis cross-sectional study examined associations between circulating...

Full description

Saved in:
Bibliographic Details
Main Authors: Lumi Zhang, Duanbin Li, Na Zhao, Guoping Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Human Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnhum.2025.1598495/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688306644680704
author Lumi Zhang
Duanbin Li
Na Zhao
Guoping Peng
author_facet Lumi Zhang
Duanbin Li
Na Zhao
Guoping Peng
author_sort Lumi Zhang
collection DOAJ
description IntroductionCirculating very-long-chain saturated fatty acids (VLSFAs) may attenuate age-related cognitive decline, but their direct association with neurodegeneration biomarkers and the underlying mechanisms remain unclear.MethodsThis cross-sectional study examined associations between circulating fatty acid profiles, neurodegeneration (assessed by serum neurofilament light chain, NfL), cognitive function, and hypertension in 1,677 U.S. adults from the National Health and Nutrition Examination Survey (NHANES) 2013–2014. Advanced statistical methods including weighted quantile sum (WQS) regression, Bayesian kernel machine regression (BKMR), quantile g-computation (Qgcomp), and formal mediation analyses were employed.ResultsThe VLSFA mixture demonstrated significant inverse associations with serum NfL (β = −0.044, 95% CI: -0.076, -0.011) and the prevalence of hypertension (OR = 0.788, 95% CI: 0.672, 0.923). This association with NfL was non-linear, exhibiting a more pronounced protective effect at lower VLSFA concentrations. Higher VLSFA levels were significantly correlated with better cognitive performance, particularly in processing speed (Digit-Symbol Substitution Test) and memory (delayed recall). Hypertension was positively associated with NfL (β=4.133, 95% CI: 1.705, 6.562), an effect driven primarily by systolic blood pressure. Mediation analysis revealed that hypertension accounted for approximately 15–20% of the total association between VLSFAs and NfL.DiscussionCirculating VLSFAs are inversely associated with the neurodegeneration biomarker NfL and positively correlated with cognitive performance. This neuroprotective association appears to be partially mediated by blood pressure regulation pathways. These findings identify VLSFAs as a potential therapeutic target, warranting further longitudinal and interventional studies to confirm their role in mitigating neurodegeneration.
format Article
id doaj-art-6fd4abf82cea42ceb8cdacbd1d70f67e
institution DOAJ
issn 1662-5161
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Human Neuroscience
spelling doaj-art-6fd4abf82cea42ceb8cdacbd1d70f67e2025-08-20T03:22:03ZengFrontiers Media S.A.Frontiers in Human Neuroscience1662-51612025-06-011910.3389/fnhum.2025.15984951598495Serum lipidomic analysis identifies potential therapeutic targets for neurodegenerationLumi Zhang0Duanbin Li1Na Zhao2Guoping Peng3Department of Neurology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Neurology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, ChinaDepartment of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaIntroductionCirculating very-long-chain saturated fatty acids (VLSFAs) may attenuate age-related cognitive decline, but their direct association with neurodegeneration biomarkers and the underlying mechanisms remain unclear.MethodsThis cross-sectional study examined associations between circulating fatty acid profiles, neurodegeneration (assessed by serum neurofilament light chain, NfL), cognitive function, and hypertension in 1,677 U.S. adults from the National Health and Nutrition Examination Survey (NHANES) 2013–2014. Advanced statistical methods including weighted quantile sum (WQS) regression, Bayesian kernel machine regression (BKMR), quantile g-computation (Qgcomp), and formal mediation analyses were employed.ResultsThe VLSFA mixture demonstrated significant inverse associations with serum NfL (β = −0.044, 95% CI: -0.076, -0.011) and the prevalence of hypertension (OR = 0.788, 95% CI: 0.672, 0.923). This association with NfL was non-linear, exhibiting a more pronounced protective effect at lower VLSFA concentrations. Higher VLSFA levels were significantly correlated with better cognitive performance, particularly in processing speed (Digit-Symbol Substitution Test) and memory (delayed recall). Hypertension was positively associated with NfL (β=4.133, 95% CI: 1.705, 6.562), an effect driven primarily by systolic blood pressure. Mediation analysis revealed that hypertension accounted for approximately 15–20% of the total association between VLSFAs and NfL.DiscussionCirculating VLSFAs are inversely associated with the neurodegeneration biomarker NfL and positively correlated with cognitive performance. This neuroprotective association appears to be partially mediated by blood pressure regulation pathways. These findings identify VLSFAs as a potential therapeutic target, warranting further longitudinal and interventional studies to confirm their role in mitigating neurodegeneration.https://www.frontiersin.org/articles/10.3389/fnhum.2025.1598495/fullVLSFANfLneurodegenerationhypertensionNHANES
spellingShingle Lumi Zhang
Duanbin Li
Na Zhao
Guoping Peng
Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
Frontiers in Human Neuroscience
VLSFA
NfL
neurodegeneration
hypertension
NHANES
title Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
title_full Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
title_fullStr Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
title_full_unstemmed Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
title_short Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
title_sort serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
topic VLSFA
NfL
neurodegeneration
hypertension
NHANES
url https://www.frontiersin.org/articles/10.3389/fnhum.2025.1598495/full
work_keys_str_mv AT lumizhang serumlipidomicanalysisidentifiespotentialtherapeutictargetsforneurodegeneration
AT duanbinli serumlipidomicanalysisidentifiespotentialtherapeutictargetsforneurodegeneration
AT nazhao serumlipidomicanalysisidentifiespotentialtherapeutictargetsforneurodegeneration
AT guopingpeng serumlipidomicanalysisidentifiespotentialtherapeutictargetsforneurodegeneration